Skip to main content
Premium Trial:

Request an Annual Quote

Integrated Diagnostics Secures $10M in Series A Tranche

NEW YORK (GenomeWeb News) – Integrated Diagnostics today announced it has secured $10 million in a third tranche of its Series A financing round.

The tranche was triggered after the Seattle-based firm made "substantial progress in its diagnostic programs," it said.

The funds will be used to complete clinical development of its in vitro proteomic-based diagnostic programs to prepare the for a commercial launch. Also, funds will be used toward advancing the company's protein-catalyzed capture agents for use in in vivo molecular imaging and therapeutics.

The tranche, which completes Integrated Diagnostics Series A round, was led by InterWest Partners, which was joined by the Wellcome Trust and the Grand Duchy of Luxembourg.

The company was founded by Leroy Hood and launched in 2009 with $30 million in financing. Last month, it and Agilent Technologies partnered to develop multiplexed biomarker-based assays for the detection of diseases in the early stages.

The company also announced today the hiring of Donald Seaton as its CFO, and James Garner as its chief business officer.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.